Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Body and Mind's earnings before interest and taxes (EBIT) for the
three
months ended in Apr. 2024 was $-2.01 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2024 was $-16.91 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Body and Mind's annualizedROC % for the quarter that ended in Apr. 2024 was -34.68%.
Body and Mind's annualizedROC (Joel Greenblatt) % for the quarter that ended in Apr. 2024 was -140.40%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Body and Mind's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2024 was -141.15%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Body and Mind EBIT Related Terms
Body and Mind EBIT Historical Data
* Premium members only.
The historical data trend for Body and Mind's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Body and Mind's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Body and Mind EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Body and Mind's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Body and Mind's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.91 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Body and Mind (BMMJ) has a EBIT of $-16.91 Mil as of Apr. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Body and Mind.
Is Body and Mind's EBIT too high?
Body and Mind's current EBIT is $-16.91 Mil. Overall, Body and Mind has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Body and Mind's EBIT compare to AKAN and OWPC?
Body and Mind's EBIT of $-16.91 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Body and Mind. Body and Mind's current EBIT is $-16.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Body and Mind stock overvalued right now?
Body and Mind (BMMJ) has a current EBIT of $-16.91 Mil. The current EBIT is $-16.91 Mil. Body and Mind's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Body and Mind (BMMJ), the current EBIT is $-16.91 Mil as of Apr. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Body and Mind Inc is a multi-state cannabis operator, which has retail, distribution, cultivation, and/or processing operations in Nevada, California, Arkansas, Ohio and Illinois. It has developed the marquis lifestyle Body and Mind brand in Nevada with penetration into dispensaries and has expanded its brand and products to dispensaries in California. The Body and Mind brand appeals to a wide range of cannabis consumers with products including flowers, oils, extracts (wax, live resin, ambrosia), and edibles. The Company Operates in Three segments; Wholesale, Retail, and All others. The Majority of revenue is derived from the Retail segment.
14GF Score
Get the complete analysis for BMMJ
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMMJ has been successfully added to your 
